Skip to main content

Company Profile Philosophy Milestones Organization Leadership Team R&D Team

Diabetes Care CDMO & Transfer Technology

Board of Directors Material Information Governance Documents Financial Information Shareholders Shareholder Services Investor Conference Committees Sustainability Reports

Environment Social Governance Stakeholder Engagement

Financial Information

Monthly revenue, quarterly and annual report downloads

Home
/ Investor Relations
/ Financial Information

Investor Relations ／Financial Information

Board of Directors
Material Information
Governance Documents
Financial Information
Shareholders
Shareholder Services
Investor Conference
Committees
Sustainability Reports
Technology

Monthly Revenue

2025 Jan
2025 Feb
2025 Mar

2024 Jan
2024 Feb
2024 Mar
2024 Apr
2024 May
2024 Jun
2024 Jul
2024 Aug
2024 Sep
2024 Oct
2024 Nov
2024 Dec

Quarterly Reports

2025 Q1

2024 Q1
2024 Q2
2024 Q3
2024 Q4

2023 Q1
2023 Q2
2023 Q3
2023 Q4

Annual Reports

2024 Annual Reports
2023 Annual Reports
2022 Annual Reports

HMD

HMD Biomedical Inc.

Founded in 2000, HMD Biomedical is dedicated to medical biotechnology and solutions in human health and healthcare, specializing in blood glucose monitoring systems.

No. 181, Minsheng St., Xinpu Township, Hsinchu 305, Taiwan 03-5895-000 sales@hmdbio.com

About Us

Company Profile
Philosophy
Milestones
Organization
Leadership Team
R&D Team

Products & Technology

Diabetes Care
CDMO & Transfer
Technology

Investor Relations

Board of Directors
Material Information
Governance Documents
Financial Information
Shareholders
Shareholder Services
Investor Conference
Committees
Sustainability Reports

ESG

Environment
Social
Governance
Stakeholder Engagement

© 2026 HMD Biomedical Inc.. All rights reserved. Privacy Policy ・ Terms of Service ・ Design by CS Studio.